BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25216413)

  • 1. Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.
    Nozoe T; Matono R; Ijichi H; Ohga T; Ezaki T
    Int Surg; 2014; 99(5):512-7. PubMed ID: 25216413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.
    Hirashima K; Watanabe M; Shigaki H; Imamura Y; Ida S; Iwatsuki M; Ishimoto T; Iwagami S; Baba Y; Baba H
    J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
    Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
    Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma.
    Mohammed AA; Al-Zahrani O; Elsayed FM
    Indian J Palliat Care; 2022; 28(4):406-412. PubMed ID: 36447500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Am J Surg; 2013 Jan; 205(1):22-8. PubMed ID: 23116639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
    Tong T; Guan Y; Xiong H; Wang L; Pang J
    Front Oncol; 2020; 10():1541. PubMed ID: 33042799
    [No Abstract]   [Full Text] [Related]  

  • 15. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
    Nie D; Zhang L; Wang C; Guo Q; Mao X
    Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E
    Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
    Zhang Y; Chen S; Chen H; Li W
    Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
    Woo HD; Kim K; Kim J
    Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
    Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
    Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.
    Kobayashi T; Kawakamil M; Hara Y; Shioiri S; Yasuno M; Teruya M; Kaminishi M
    Hepatogastroenterology; 2014; 61(133):1359-62. PubMed ID: 25436311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.